MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/crj.70063

Медицинская библиотека · The clinical respiratory journal · 2025

Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia.

Machado-Duque Manuel, Gaviria-Mendoza Andrés, Valladales-Restrepo Luis Fernando, Pacheco Manuel, Franco Juan Sebastián, Del Rosario Forero María, Suarez Rubiela, Peñuela Oscar, Machado-Alba Jorge E

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Pulmonary hypertension (PH) is a chronic disease characterized by a progressive rise in pulmonary artery blood pressure. The objective was to describe the treatment patterns among ambulatory patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in a real-world setting.

METHODS

This is a longitudinal cohort follow-up study characterizing the treatment patterns of patients diagnosed with PAH or CTEPH, with secondary data from a population-based drug-dispensing database between 2022 and 2023, which includes sociodemographic, diagnosis, prescribing specialty, and treatment (drugs, persistence of use, and concomitant medications).

RESULTS

In total, 1045 patients with a diagnosis of PH were identified, with mean age of 62.9 ± 18.2 years, and 72.3% of females; of which 947 (90.6%) received monotherapy, and 98 (9.4%) received combination therapy at the beginning of follow-up. The most frequently used drugs for the treatment of PH were calcium channel blockers (58.1%), followed by phosphodiesterase 5 inhibitors (41.1%), endothelin receptor antagonist (32.5%), and guanylate cyclase stimulants (9.7%). The schemes used most frequently were monotherapy with amlodipine (31.0%), sildenafil (19.2%), or nifedipine (10.0%), but the main combination were sildenafil with nifedipine (2.5%). The mean of persistence of use was 161 ± 123 days during 1 year of follow-up.

CONCLUSIONS

This group of patients with PH from Colombia were treated predominantly with monotherapy of calcium channel blockers and phosphodiesterase 5 inhibitors. However, current clinical practice guidelines recommend the use of combined therapy. The average persistence of the use of drugs for treatment for less than 6 months may be associated with difficulties in follow-up, adherence, effectiveness, tolerability, and access.

Для цитирования: Machado-Duque Manuel, Gaviria-Mendoza Andrés, Valladales-Restrepo Luis Fernando, Pacheco Manuel, Franco Juan Sebastián, Del Rosario Forero María, Suarez Rubiela, Peñuela Oscar, Machado-Alba Jorge E. Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia.. The clinical respiratory journal. 2025. DOI: 10.1111/crj.70063.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.